189 related articles for article (PubMed ID: 9818754)
1. Susceptibility of penicillin-susceptible and -resistant pneumococci to CFC-222, a new fluoroquinolone.
Kim JH; Kang JA; Lee Y; Lee KH; Lee JH; Choi EC; Kim BK
J Antimicrob Chemother; 1998 Oct; 42(4):527-30. PubMed ID: 9818754
[TBL] [Abstract][Full Text] [Related]
2. Emergence of penicillin-resistant Streptococcus pneumoniae ocular infections.
Penland RL; Wilhelmus KR
Cornea; 1998 Mar; 17(2):135-40. PubMed ID: 9520187
[TBL] [Abstract][Full Text] [Related]
3. In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Frémaux A; Sissia G; Geslin P
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():9-14. PubMed ID: 10404331
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.
Jones RN; Ballow CH; Schentag JJ; Johnson DM; Deinhart JA
Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392
[TBL] [Abstract][Full Text] [Related]
5. Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolates. Austrian Bacterial Surveillance Network.
Buxbaum A; Straschil U; Moser C; Graninger W; Georgopoulos A
J Antimicrob Chemother; 1999 May; 43 Suppl B():13-8. PubMed ID: 10382870
[TBL] [Abstract][Full Text] [Related]
6. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
Esposito S; Noviello S; Ianniello F
Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococci.
Spangler SK; Jacobs MR; Appelbaum PC
Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):965-7. PubMed ID: 8187796
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia.
Urbásková P; Trupl J; Hupková H; Appelbaum PC; Jacobs MR
Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):686-8. PubMed ID: 8894582
[TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1992 Apr; 36(4):856-9. PubMed ID: 1323956
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance.
Thornsberry C; Ogilvie PT; Holley HP; Sahm DF
Clin Ther; 1998; 20(6):1179-90. PubMed ID: 9916611
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.
Spangler SK; Jacobs MR; Pankuch GA; Appelbaum PC
J Antimicrob Chemother; 1993 Feb; 31(2):273-80. PubMed ID: 8463172
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin.
Klugman KP; Capper T
J Antimicrob Chemother; 1997 Dec; 40(6):797-802. PubMed ID: 9462430
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
White RL; Enzweiler KA; Friedrich LV; Wagner D; Hoban D; Bosso JA
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):207-17. PubMed ID: 12106954
[TBL] [Abstract][Full Text] [Related]
14. Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group.
Jones RN; Johnson DM; Erwin ME; Beach ML; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):91-8. PubMed ID: 10354857
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae.
Reinert RR; Lütticken R; Lemperle M; Bryskier A
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():5-8. PubMed ID: 10404330
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance of pneumococci in Norway.
Bergan T; Gaustad P; Høiby EA; Berdal BP; Furuberg G; Baann J; Tønjum T
Int J Antimicrob Agents; 1998 Apr; 10(1):77-81. PubMed ID: 9624547
[TBL] [Abstract][Full Text] [Related]
17. Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.
Thomson KS; Chartrand SA; Sanders CC; Block SL
Antimicrob Agents Chemother; 1997 Feb; 41(2):478-80. PubMed ID: 9021213
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of moxifloxacin, penicillin, ceftriaxone and ciprofloxacin against pneumococci isolated from meningitis.
Tarasi A; Capone A; Tarasi D; Cassone M; Bianco G; Venditti M
J Antimicrob Chemother; 1999 Jun; 43(6):833-5. PubMed ID: 10404324
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.
Lemmen S; Al-Lahham A; Lütticken R; Reinert RR
Chemotherapy; 2001; 47(2):104-9. PubMed ID: 11173811
[TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.
Klugman KP; Gootz TD
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():51-5. PubMed ID: 9222070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
